These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36498905)

  • 1. A Proof-of-Concept Analysis of Plasma-Derived Exosomal microRNAs in Interstitial Pulmonary Fibrosis Secondary to Antisynthetase Syndrome.
    Bozzini S; Zanframundo G; Bagnera C; Bozza E; Lettieri S; Vertui V; Codullo V; Cuzzocrea F; Atienza-Mateo B; Remuzgo Martinez S; Montecucco C; González-Gay MA; Cavagna L; Meloni F
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of MUC1 rs4072037 polymorphism and serum KL-6 levels in patients with antisynthetase syndrome.
    Remuzgo-Martínez S; Atienza-Mateo B; Ocejo-Vinyals JG; Genre F; Pulito-Cueto V; Mora-Cuesta VM; Iturbe-Fernández D; Lera-Gómez L; Pérez-Fernández R; Prieto-Peña D; Irure J; Romero-Bueno F; Sanchez-Pernaute O; Alonso-Moralejo R; Nuño L; Bonilla G; Vicente-Rabaneda EF; Grafia I; Prieto-González S; Narvaez J; Trallero-Araguas E; Selva-O'Callaghan A; ; ; Gualillo O; Cavagna L; Cifrián JM; Renzoni EA; Castañeda S; López-Mejías R; González-Gay MA
    Sci Rep; 2021 Nov; 11(1):22574. PubMed ID: 34799647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of MUC5B gene on antisynthetase syndrome.
    López-Mejías R; Remuzgo-Martínez S; Genre F; Pulito-Cueto V; Rozas SMF; Llorca J; Fernández DI; Cuesta VMM; Ortego-Centeno N; Gómez NP; Mera-Varela A; Martínez-Barrio J; López-Longo FJ; Mijares V; Lera-Gómez L; Usetti MP; Laporta R; Pérez V; Gafas AP; González MAA; Calvo-Alén J; Romero-Bueno F; Sanchez-Pernaute O; Nuno L; Bonilla G; Balsa A; Hernández-González F; Grafia I; Prieto-González S; Narvaez J; Trallero-Araguas E; Selva-O'Callaghan A; Gualillo O; Castañeda S; Cavagna L; Cifrian JM; González-Gay MA
    Sci Rep; 2020 Jan; 10(1):1415. PubMed ID: 31996780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma-Derived Exosomal hsa-miR-4488 and hsa-miR-1228-5p: Novel Biomarkers for Dermatomyositis-Associated Interstitial Lung Disease with Anti-Melanoma Differentiation-Associated Protein 5 Antibody-Positive Subset.
    Zhong D; Wu C; Xu D; Bai J; Wang Q; Zeng X
    Biomed Res Int; 2021; 2021():6676107. PubMed ID: 34368354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interstitial lung disease progression in patients with anti-aminoacyl transfer-RNA-synthetase autoantibodies is characterized by higher levels of sCD163.
    Ramos-Martínez E; Falfán-Valencia R; Pérez-Rubio G; Mejía M; Mejía-Hurtado JG; Buendía-Roldán I; González-Pérez MI; Mateos-Toledo HN; Rojas-Serrano J
    Immunol Lett; 2022 Aug; 248():56-61. PubMed ID: 35728747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China.
    Zhan X; Yan W; Wang Y; Li Q; Shi X; Gao Y; Ye Q
    BMC Pulm Med; 2021 Feb; 21(1):57. PubMed ID: 33579248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics and clinical significance of pulmonary function test and KL-6 in ASSD-ILD and IPF].
    Sun D; Cheng Z; Jiang TC; Li PF; Jia LQ; Wang TT; Zheng CP; Li Y; Duo MJ
    Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(10):748-752. PubMed ID: 32192286
    [No Abstract]   [Full Text] [Related]  

  • 8. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
    Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Watanabe K; Aihara K; Ikezoe K; Sokai A; Nakatsuka Y; Taguchi Y; Hatta K; Noma S; Kobashi Y; Yoshizawa A; Oga T; Hirai T; Chin K; Nagai S; Izumi T; Mimori T; Mishima M
    Respir Med; 2017 Jun; 127():57-64. PubMed ID: 28461123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression and clinical significance of plasma exosomal miR-34-5p and miR-142-3p in systemic sclerosis].
    Li WG; Gu XD; Weng RQ; Liu SD; Chen C
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1022-1027. PubMed ID: 38101783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Ro52 antibodies positivity in antisynthetase syndrome: a single centre cohort study.
    Bozzalla-Cassione E; Zanframundo G; Biglia A; Bellis E; Bozzini S; Codullo V; Vertui V; Alpini C; Valentini A; Preda L; Montecucco C; Meloni F; Cavagna L
    Clin Exp Rheumatol; 2022 May; 40 Suppl 134(5):27-31. PubMed ID: 35349417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage-derived exosomes attenuate fibrosis in airway epithelial cells through delivery of antifibrotic miR-142-3p.
    Guiot J; Cambier M; Boeckx A; Henket M; Nivelles O; Gester F; Louis E; Malaise M; Dequiedt F; Louis R; Struman I; Njock MS
    Thorax; 2020 Oct; 75(10):870-881. PubMed ID: 32759383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantigenic properties of the aminoacyl tRNA synthetase family in idiopathic inflammatory myopathies.
    Preger C; Notarnicola A; Hellström C; Wigren E; Fernandes-Cerqueira C; Kvarnström M; Wahren-Herlenius M; Idborg H; Lundberg IE; Persson H; Gräslund S; Jakobsson PJ
    J Autoimmun; 2023 Jan; 134():102951. PubMed ID: 36470210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicoserological features of antisynthetase syndrome (ASyS)-associated interstitial lung disease presenting to respiratory services: comparison with idiopathic pulmonary fibrosis and ASyS diagnosed in rheumatology services.
    Barratt SL; Adamali HH; Cotton C; Mulhearn B; Iftikhar H; Pauling JD; Spencer L; Adamali HI; Gunawardena H
    BMJ Open Respir Res; 2021 Jan; 8(1):. PubMed ID: 33419741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. hsa-miR-7 Is a Potential Biomarker for Idiopathic Inflammatory Myopathies with Interstitial Lung Disease in Humans.
    Yu L; Li J; Chen Y; Jiang J; Fang Q; Jiang J; Wang D; Liu M
    Ann Clin Lab Sci; 2018 Nov; 48(6):764-769. PubMed ID: 30610047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study.
    Cavagna L; Nuño L; Scirè CA; Govoni M; Longo FJL; Franceschini F; Neri R; Castañeda S; Giraldo WAS; Caporali R; Iannone F; Fusaro E; Paolazzi G; Pellerito R; Schwarting A; Saketkoo LA; Ortego-Centeno N; Quartuccio L; Bartoloni E; Specker C; Murcia TP; La Corte R; Furini F; Foschi V; Corral JB; Airò P; Cavazzana I; Martínez-Barrio J; Hinojosa M; Giannini M; Barsotti S; Menke J; Triantafyllias K; Vitetta R; Russo A; Bajocchi G; Bravi E; Barausse G; Bortolotti R; Selmi C; Parisi S; Montecucco C; González-Gay MA;
    Medicine (Baltimore); 2015 Aug; 94(32):e1144. PubMed ID: 26266346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpressed microRNA-140 inhibits pulmonary fibrosis in interstitial lung disease via the Wnt signaling pathway by downregulating osteoglycin.
    Shi S; Li H
    Am J Physiol Cell Physiol; 2020 Nov; 319(5):C895-C905. PubMed ID: 32755451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosome-Derived microRNA-22 Ameliorates Pulmonary Fibrosis by Regulating Fibroblast-to-Myofibroblast Differentiation in Vitro and in Vivo.
    Kuse N; Kamio K; Azuma A; Matsuda K; Inomata M; Usuki J; Morinaga A; Tanaka T; Kashiwada T; Atsumi K; Hayashi H; Saito Y; Seike M; Gemma A
    J Nippon Med Sch; 2020 Jul; 87(3):118-128. PubMed ID: 31776321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Regulation of Fatty Acid Synthase by Exosomal miR-143-5p and miR-342-5p in Idiopathic Pulmonary Fibrosis.
    Hayek H; Rehbini O; Kosmider B; Brandt T; Chatila W; Marchetti N; Criner GJ; Bolla S; Kishore R; Bowler RP; Bahmed K
    Am J Respir Cell Mol Biol; 2024 Apr; 70(4):259-282. PubMed ID: 38117249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic analysis and microRNA expression profiling of plasma-derived exosomes in primary immune thrombocytopenia.
    Sun Y; Hou Y; Meng G; Han P; Zhao Y; Wang H; Xu M; Wang Y; Qiu J; Peng J; Shao L; Sun L; Hou M
    Br J Haematol; 2021 Sep; 194(6):1045-1052. PubMed ID: 34337736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Searching for airways biomarkers useful to identify progressive pulmonary fibrosis.
    Soccio P; Moriondo G; Scioscia G; Leo V; Tondo P; Salerno L; Palange P; Barbaro MPF; Lacedonia D
    BMC Pulm Med; 2023 Oct; 23(1):407. PubMed ID: 37884953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.